Symbols / BJDX $1.95 +3.17% Bluejay Diagnostics, Inc.

Healthcare • Medical Devices • United States • NCM
BJDX Chart
About

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 2.02M
Enterprise Value -3.14M Income -6.85M Sales —
Book/sh 9.88 Cash/sh 5.31 Dividend Yield —
Payout 0.00% Employees 6 IPO —
P/E 0.00 Forward P/E -6.09 PEG —
P/S — P/B 0.20 P/C —
EV/EBITDA 0.46 EV/Sales — Quick Ratio 4.62
Current Ratio 4.88 Debt/Eq 2.17 LT Debt/Eq —
EPS (ttm) -15.25 EPS next Y -0.32 EPS Growth —
Revenue Growth — Earnings 2024-03-28 17:00 ROA -62.76%
ROE -117.02% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 1.03M
Shs Float 852.16K Short Float 5.86% Short Ratio 0.14
Short Interest — 52W High 40.80 52W Low 1.65
Beta 0.67 Avg Volume 231.87K Volume 10.00K
Target Price — Recom None Prev Close $1.89
Price $1.95 Change 3.17%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.95
Latest analyst target
3. DCF / Fair value
$-64.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.95
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-08-03 down Dawson James Buy → Neutral —
News
RSS: Latest BJDX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
-100.00%
0.25
Operating Revenue
0.00
0.00
0.00
-100.00%
0.25
Cost Of Revenue
—
—
0.00
-100.00%
0.20
Reconciled Cost Of Revenue
—
—
0.00
-100.00%
0.20
Gross Profit
—
—
0.00
-100.00%
0.05
Operating Expense
6.95
-3.02%
7.17
-30.47%
10.31
+10.08%
9.37
Research And Development
3.05
-12.25%
3.47
-39.25%
5.71
+37.63%
4.15
Selling General And Administration
3.91
+5.64%
3.70
-19.55%
4.60
-11.85%
5.21
Selling And Marketing Expense
0.00
-100.00%
0.01
-97.07%
0.28
-37.21%
0.45
General And Administrative Expense
3.91
+5.88%
3.69
-14.46%
4.31
-9.45%
4.76
Other Gand A
3.91
+5.88%
3.69
-14.46%
4.31
-9.45%
4.76
Other Operating Expenses
—
—
—
—
Total Expenses
6.95
-3.02%
7.17
-30.47%
10.31
+7.78%
9.57
Operating Income
-6.95
+3.02%
-7.17
+30.47%
-10.31
-10.66%
-9.32
Total Operating Income As Reported
-6.95
+3.02%
-7.17
+30.47%
-10.31
-10.66%
-9.32
EBITDA
-6.68
+0.28%
-6.70
+27.01%
-9.17
-1.79%
-9.01
Normalized EBITDA
-6.68
+0.28%
-6.70
+27.01%
-9.17
-4.55%
-8.77
Reconciled Depreciation
0.17
-14.27%
0.20
-74.51%
0.78
+154.91%
0.31
EBIT
-6.85
+0.68%
-6.89
+30.73%
-9.95
-6.83%
-9.32
Total Unusual Items
—
—
0.00
+100.00%
-0.24
Total Unusual Items Excluding Goodwill
—
—
0.00
+100.00%
-0.24
Special Income Charges
—
—
0.00
+100.00%
-0.24
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
—
0.00
-100.00%
0.24
Net Income
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Pretax Income
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Net Non Operating Interest Income Expense
0.10
+114.28%
-0.68
-510.68%
0.16
+83.89%
0.09
Interest Expense Non Operating
0.00
-99.90%
0.82
0.00
0.00
Net Interest Income
0.10
+114.28%
-0.68
-510.68%
0.16
+83.89%
0.09
Interest Expense
0.00
-99.90%
0.82
0.00
0.00
Interest Income Non Operating
0.10
-33.10%
0.15
-11.57%
0.16
+83.89%
0.09
Interest Income
0.10
-33.10%
0.15
-11.57%
0.16
+83.89%
0.09
Other Income Expense
0.01
-93.98%
0.13
-32.95%
0.19
+379.51%
-0.07
Other Non Operating Income Expenses
0.01
-93.98%
0.13
-32.95%
0.19
+14.23%
0.17
Gain On Sale Of Security
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Net Income From Continuing Operation Net Minority Interest
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Net Income From Continuing And Discontinued Operation
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Net Income Continuous Operations
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Normalized Income
-6.85
+11.26%
-7.72
+22.46%
-9.95
-9.87%
-9.06
Net Income Common Stockholders
-6.85
+67.30%
-20.94
-110.38%
-9.95
-7.07%
-9.30
Otherunder Preferred Stock Dividend
0.00
-100.00%
13.22
0.00
—
Diluted EPS
—
-456.75
+96.45%
-12,860.32
+12.71%
-14,733.67
Basic EPS
—
-456.75
+96.45%
-12,860.32
+12.71%
-14,733.67
Basic Average Shares
—
0.05
+5823.51%
0.00
+22.66%
0.00
Diluted Average Shares
—
0.05
+5823.51%
0.00
+22.66%
0.00
Diluted NI Availto Com Stockholders
-6.85
+67.30%
-20.94
-110.38%
-9.95
-7.07%
-9.30
Line Item Trend 2022-12-31
Total Assets
13.52
Current Assets
11.79
Cash Cash Equivalents And Short Term Investments
10.11
Cash And Cash Equivalents
10.11
Inventory
—
Prepaid Assets
1.43
Current Deferred Assets
0.00
Assets Held For Sale Current
—
Other Current Assets
0.24
Total Non Current Assets
1.73
Net PPE
1.70
Gross PPE
2.29
Accumulated Depreciation
-0.60
Properties
0.00
Buildings And Improvements
0.47
Machinery Furniture Equipment
0.14
Construction In Progress
0.38
Other Properties
1.73
Leases
0.04
Goodwill And Other Intangible Assets
0.00
Other Intangible Assets
0.00
Other Non Current Assets
0.04
Total Liabilities Net Minority Interest
1.98
Current Liabilities
1.64
Payables And Accrued Expenses
1.47
Payables
0.64
Accounts Payable
0.64
Current Accrued Expenses
0.84
Current Debt And Capital Lease Obligation
0.17
Current Capital Lease Obligation
0.17
Total Non Current Liabilities Net Minority Interest
0.34
Long Term Debt And Capital Lease Obligation
0.32
Long Term Capital Lease Obligation
0.32
Other Non Current Liabilities
0.02
Preferred Securities Outside Stock Equity
—
Stockholders Equity
11.54
Common Stock Equity
11.54
Capital Stock
0.00
Common Stock
0.00
Share Issued
0.00
Ordinary Shares Number
0.00
Treasury Shares Number
0.00
Additional Paid In Capital
28.54
Retained Earnings
-17.00
Total Equity Gross Minority Interest
11.54
Total Capitalization
11.54
Working Capital
10.15
Invested Capital
11.54
Total Debt
0.49
Capital Lease Obligations
0.49
Net Tangible Assets
11.54
Tangible Book Value
11.54
Current Notes Payable
—
Dueto Related Parties Current
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-6.05
+22.60%
-7.82
+5.93%
-8.31
-7.39%
-7.74
Cash Flow From Continuing Operating Activities
-6.05
+22.60%
-7.82
+5.93%
-8.31
-7.39%
-7.74
Net Income From Continuing Operations
-6.85
+11.26%
-7.72
+22.46%
-9.95
-7.07%
-9.30
Depreciation Amortization Depletion
0.17
-14.27%
0.20
-74.51%
0.78
+154.91%
0.31
Depreciation
0.17
-14.27%
0.20
-74.51%
0.78
+154.91%
0.31
Depreciation And Amortization
0.17
-14.27%
0.20
-74.51%
0.78
+154.91%
0.31
Other Non Cash Items
—
0.31
+23468.05%
0.00
—
Stock Based Compensation
0.00
-99.97%
0.02
-89.38%
0.19
-56.29%
0.43
Asset Impairment Charge
—
—
0.00
-99.25%
0.24
Operating Gains Losses
0.04
+1158.78%
0.00
+90.88%
0.00
+1204.38%
0.00
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
0.04
+1158.78%
0.00
+90.88%
0.00
+1204.38%
0.00
Change In Working Capital
0.58
+191.80%
-0.63
-194.97%
0.67
+15.24%
0.58
Change In Receivables
—
—
—
—
Changes In Account Receivables
—
—
—
—
Change In Inventory
—
—
—
0.00
Change In Prepaid Assets
0.33
+122.11%
0.15
-83.77%
0.93
+2371.70%
-0.04
Change In Payables And Accrued Expense
0.22
+121.12%
-1.04
-291.67%
-0.27
-142.00%
0.63
Change In Accrued Expense
0.15
+121.69%
-0.70
-2197.48%
-0.03
-109.00%
0.34
Change In Payable
0.07
+119.96%
-0.35
-46.91%
-0.24
-179.41%
0.30
Change In Account Payable
0.07
+119.96%
-0.35
-46.91%
-0.24
-178.88%
0.30
Change In Other Working Capital
—
0.27
—
—
Change In Other Current Assets
0.03
+514.80%
-0.01
-200.70%
0.01
+146.14%
-0.01
Investing Cash Flow
-0.17
+43.37%
-0.31
+56.43%
-0.70
+41.28%
-1.20
Cash Flow From Continuing Investing Activities
-0.17
+43.37%
-0.31
+56.43%
-0.70
+41.28%
-1.20
Net PPE Purchase And Sale
-0.17
+43.37%
-0.31
+56.43%
-0.70
+41.28%
-1.20
Purchase Of PPE
-0.17
+43.37%
-0.31
+56.43%
-0.70
+41.28%
-1.20
Capital Expenditure
-0.17
+43.37%
-0.31
+56.43%
-0.70
+41.28%
-1.20
Financing Cash Flow
7.09
-30.63%
10.22
+819.52%
1.11
+13665.47%
0.01
Cash Flow From Continuing Financing Activities
7.09
-30.63%
10.22
+819.52%
1.11
+13665.47%
0.01
Net Issuance Payments Of Debt
-0.00
-7.27%
-0.00
+21.91%
-0.00
-500.12%
-0.00
Issuance Of Debt
0.00
-100.00%
2.00
0.00
0.00
Repayment Of Debt
-0.00
+99.80%
-2.00
-41584.09%
-0.00
-500.12%
-0.00
Long Term Debt Issuance
0.00
-100.00%
2.00
0.00
0.00
Long Term Debt Payments
-0.00
+99.80%
-2.00
-41584.09%
-0.00
-500.12%
-0.00
Net Long Term Debt Issuance
-0.00
-7.27%
-0.00
+21.91%
-0.00
-500.12%
-0.00
Net Common Stock Issuance
8.35
-30.84%
12.07
+658.66%
1.59
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.00
0.00
-100.00%
0.03
Net Other Financing Charges
-1.25
+32.11%
-1.84
-288.82%
-0.47
-2272.36%
-0.02
Changes In Cash
0.86
-58.78%
2.09
+126.48%
-7.91
+11.49%
-8.93
Beginning Cash Position
4.30
+94.79%
2.21
-78.17%
10.11
-46.90%
19.05
End Cash Position
5.16
+20.06%
4.30
+94.79%
2.21
-78.17%
10.11
Free Cash Flow
-6.23
+23.38%
-8.13
+9.87%
-9.02
-0.86%
-8.94
Interest Paid Supplemental Data
—
—
0.00
+258.52%
0.00
Common Stock Issuance
8.35
-30.84%
12.07
+658.66%
1.59
0.00
Issuance Of Capital Stock
8.35
-30.84%
12.07
+658.66%
1.59
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category